New Jersey Medical School Clinical Research Center is the only site in the state participating in a worldwide effort to enroll 3,800 HIV negative individuals in the first Phase 3 HIV vaccine efficacy trial conducted in more than a decade. To read the full article.
Recent Posts
- How Gender Bias Influences Math Education.
- Join NJ ACTS for Special Populations Seminar on 4/28 at 12pm
- Drug Metabolism Group Spring Symposium and Vendor Exhibition on May 5th
- Rutgers Health Begins Clinical Trial to Determine If B1 Can Slow Alzheimer’s Disease.
- Join NJACTS on 4/29 for a Multilingual Research Methods Workshop – Register by 4/22!
Categories
- Community (2,476)
- Covid (999)
- CTO Events (6)
- News (3,141)
- Pilots (21)